Fundraising FoxSofinnova Ventures — 2016 Investments
3 investments dated 2016 · listed companies and verified rows first · show all
Ligand is a royalty aggregator that finances late-stage clinical development and commercialization programs for biopharmaceutical companies.
BiotechFintechLa Jolla, US
Brook Byers(Co-founder)inMATTHEW W. FOEHR(Director)JOHN L. HIGGINS(Executive Officer, Director)inMATTHEW KORENBERG(Director)inCHARLES S. BERKMAN(Director)inTodd Davis(Chief Executive Officer)in
Co-investorsSignet Healthcare PartnersVenrock
Iterum Therapeutics develops anti-infective compounds to treat infections caused by multi-drug resistant pathogens.
BiotechDigital HealthHealthtechMedical DevicesDublin, US
Michael W. Dunne(Executive Officer, Promoter)inCorey N. Fishman(Executive Officer, Director, Promoter)inJudith M. Matthews(Executive Officer, Promoter)Jeff Schaffnit(Executive Officer)
BoardBrenton K. Ahrens(Director)Ronald M. Hunt(Director)
Co-investorsBay City CapitalCanaan PartnersAdvent Life SciencesDolby Family VenturesFrazier Life SciencesSofinnova Venture Partners
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Aralez Pharmaceuticals
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.